Cargando…
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected preexisting humoral immunity. SARS-CoV-2 spike glycoprotein (S)–reactive antibodies were detectable using a flow cytometry–based...
Ejemplares similares
-
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
por: Deakin, Claire T., et al.
Publicado: (2021) -
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
por: Choida, Varvara, et al.
Publicado: (2021) -
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
por: Peckham, Hannah, et al.
Publicado: (2020) -
Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration
por: Webb, Kate, et al.
Publicado: (2019) -
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
por: Faulkner, Nikhil, et al.
Publicado: (2021)